GO:0046625 sphingolipid binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0046625 (sphingolipid binding) is a molecular function describing the selective, non-covalent interaction of a protein or biomolecule with a sphingolipid, a lipid class built on sphingosine or a related sphingoid base.
• Sphingolipid-binding proteins are structurally diverse and include enzymes, receptors, trafficking factors and transcription regulators, unified by their ability to recognize sphingolipid headgroups or acyl chains.
• Sphingolipid binding underlies membrane organization, signal transduction, vesicle trafficking and metabolic control, and its disruption is linked to cancer, metabolic disease and neurodegeneration [1,4,5].
• Specific sphingolipid-binding motifs have been identified in G protein-coupled receptors, showing that lipid recognition can be encoded by short sequence elements.
• Sphingolipid binding is studied with lipid-protein interaction assays, photoaffinity labeling, lipidomics, structural biology and CRISPR-based perturbation of sphingolipid metabolic genes [1,4,7].
• CRISPR knockout, point-mutation, knock-in and overexpression models allow causal testing of sphingolipid-binding proteins and their disease relevance [4,5,6].
Description
Sphingolipid binding (GO:0046625) is the molecular function of selectively and non-covalently interacting with a sphingolipid, a class of lipids that contain the long-chain amine diol sphingosine or a closely related sphingoid base. Sphingolipids are not merely structural membrane components; they act as signaling molecules, membrane organizers and metabolic intermediates, and the proteins that bind them translate lipid chemistry into cellular decisions. Because sphingolipid-binding events are central to membrane biology, identifying and characterizing these proteins is a recurring problem in cell biology, neurobiology and cancer research [1,8]. The functional importance of this term is illustrated by the breadth of proteins reported to bind sphingolipids. A classic review catalogued sphingolipid-binding proteins across enzyme, receptor, transporter and structural classes, establishing that lipid recognition is a widespread and regulated property rather than an isolated phenomenon. More recent work has connected sphingolipid binding and metabolism to thermogenesis in beige adipocytes, hepatic gluconeogenesis, proinsulin processing and brain metastasis, demonstrating that this molecular function sits at the intersection of metabolism, endocrinology and oncology [2,4,5,7]. For researchers, GO:0046625 provides a controlled vocabulary for annotating and querying lipid-recognition functions. It enables enrichment analysis of proteomic and transcriptomic datasets, supports hypothesis generation about membrane-associated proteins, and guides the design of experiments that test whether a candidate protein directly binds a sphingolipid [1,8]. This article summarizes the definition, mechanism, key genes, disease links and research methods associated with sphingolipid binding, with all factual claims tied to published literature.
sphingolipid binding At A Glance
| GO ID | GO:0046625 |
|---|---|
| GO term | sphingolipid binding |
| Ontology | molecular_function |
| Synonym | none listed in QuickGO |
| Major function | Selective non-covalent binding to sphingolipids such as sphingosine-based lipids |
| Lipid class recognized | Sphingolipids containing sphingosine or a closely related sphingoid base |
| Representative binders | Sphingolipid-binding proteins including enzymes, receptors and trafficking factors |
| Related biology | Membrane organization, signal transduction, lipid metabolism, vesicle trafficking |
| Disease relevance | Cancer, metabolic disorders, neurodegeneration and developmental conditions |
What Is GO:0046625?
In the Gene Ontology, GO:0046625 (sphingolipid binding) is a molecular function defined as binding to a sphingolipid, a class of lipids containing the long-chain amine diol sphingosine or a closely related base (a sphingoid). The term describes a non-covalent, selective interaction between a gene product and a sphingolipid molecule. It does not by itself specify the biological outcome of the interaction, the subcellular location, or whether the sphingolipid is a substrate, a cofactor or a structural ligand; those aspects are captured by other GO terms and by experimental context.
Why Is sphingolipid binding Important in Cell Biology?
Sphingolipid binding is important because sphingolipids are both building blocks of cellular membranes and bioactive signals, and the proteins that bind them determine how these lipids are sensed, transported and converted into cellular responses. Disruption of sphingolipid-binding proteins or of the sphingolipid metabolic enzymes that generate their ligands has been linked to cancer progression, impaired glucose homeostasis, defective insulin processing and altered adipocyte thermogenesis [2,4,5,7]. Because the function is defined at the level of a single molecular interaction, GO:0046625 is a precise annotation target for functional genomics, and it supports mechanistic studies that connect lipid chemistry to physiology and disease [1,8].
• Provides a controlled annotation for proteins that directly recognize sphingolipids, enabling functional enrichment and network analysis.
• Underpins membrane microdomain organization and signal transduction, processes that depend on lipid-protein recognition.
• Connects sphingolipid metabolism to systemic physiology, including thermogenesis and glucose homeostasis [2,7].
• Is relevant to hepatic gluconeogenesis through regulation of plasma membrane sphingolipid composition.
• Has been implicated in cancer progression, including brain metastasis in EGFR-mutant lung adenocarcinoma.
• Is linked to membrane trafficking and caveolin-1 dynamics through sphingolipid-glycerolipid balance.
• Can be encoded by short sequence motifs, as shown for G protein-coupled receptors, making it tractable for mutagenesis.
• Supports drug discovery by identifying lipid-binding interfaces as potential intervention points [1,8].
• Enables interpretation of lipidomics and proteomics datasets in the context of a defined molecular function [1,4].
• Guides CRISPR-based causal experiments on sphingolipid metabolic and binding genes [4,5,6].
Molecular Mechanism of sphingolipid binding
Recognition of the sphingoid base and headgroup
In simple terms: Proteins that bind sphingolipids recognize the lipid's characteristic backbone and headgroup.
Sphingolipids share a long-chain amine diol backbone, sphingosine or a closely related sphingoid base, which distinguishes them from glycerolipids. Sphingolipid-binding proteins achieve selectivity by forming complementary surfaces that contact this backbone and, where present, the polar headgroup. The diversity of sphingolipid-binding proteins indicates that recognition can be achieved through multiple structural solutions rather than a single conserved fold. This recognition step is the defining event of GO:0046625 and is the basis for annotating a protein with this molecular function.
Binding motifs and sequence determinants
In simple terms: Some proteins contain short sequence patterns that mediate lipid binding.
A sphingolipid-binding motif has been identified in G protein-coupled receptors, demonstrating that lipid recognition can be encoded by defined sequence elements within membrane proteins. The existence of such motifs implies that sphingolipid binding can be predicted, mutated and engineered. Mutational analysis of these motifs provides a direct way to test whether a candidate protein binds sphingolipids and whether that binding is required for its function. This concept complements broader surveys showing that sphingolipid-binding proteins span many protein families.
Membrane context and lipid presentation
In simple terms: Sphingolipid binding usually happens at membranes, where lipids are presented in a bilayer.
Sphingolipids are membrane constituents, and their availability for protein binding depends on their local concentration and distribution. SPTLC3 regulates plasma membrane sphingolipid composition, which in turn influences hepatic gluconeogenesis, illustrating that the lipid environment can be actively remodeled to control downstream biology. Seipin governs caveolin-1 trafficking by modulating the balance between sphingolipids and glycerolipids, showing that proteins can influence sphingolipid presentation and thereby affect binding-dependent processes. These findings indicate that sphingolipid binding must be interpreted within the context of membrane lipid composition [4,6].
Functional consequences of sphingolipid binding
In simple terms: When a protein binds a sphingolipid, it can change signaling, transport or metabolism.
Sphingolipid binding can alter protein localization, activity or stability, and can convert lipid signals into cellular responses. In beige adipocytes, the adipokine IL-11/IL-11Ra axis constrains sphingolipid metabolism to limit thermogenic capacity, linking sphingolipid-related biology to energy expenditure. Sphingolipid subtypes differentially control proinsulin processing and systemic glucose homeostasis, demonstrating that specific sphingolipid species can direct distinct physiological outcomes. RBM10 deficiency promotes brain metastasis by modulating sphingolipid metabolism in a blood-brain barrier model, connecting sphingolipid biology to cancer dissemination. Together these studies show that sphingolipid binding and metabolism have measurable functional consequences in diverse tissues [2,5,7].
Regulation by metabolic and signaling inputs
In simple terms: The amount and type of sphingolipids, and thus binding events, are regulated by metabolic enzymes and signaling pathways.
Sphingolipid levels are controlled by biosynthetic and degradative enzymes, and perturbations in these enzymes change the ligands available for sphingolipid-binding proteins [1,4]. SPTLC3 is an example of an enzyme that shapes plasma membrane sphingolipid composition and thereby influences a physiological process. Steroidogenic factor-1 has been characterized as a sphingolipid-binding protein, indicating that sphingolipid binding can intersect with nuclear receptor biology and transcriptional regulation. These examples show that sphingolipid binding is embedded in regulatory networks rather than being a static property [3,4].
Key Genes Involved in GO:0046625 sphingolipid binding
The following genes and proteins have been experimentally linked to sphingolipid binding or to the sphingolipid metabolic context in which this molecular function operates.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SPTLC3 | Regulates plasma membrane sphingolipid composition | Links sphingolipid composition to hepatic gluconeogenesis |
| IL11 | Adipokine that constrains sphingolipid metabolism | Limits thermogenic capacity of beige adipocytes |
| IL11RA | Receptor for IL-11 | Mediates IL-11 signaling effects on sphingolipid metabolism |
| RBM10 | RNA-binding protein affecting sphingolipid metabolism | Deficiency promotes brain metastasis in EGFR-mutant lung adenocarcinoma |
| BSCL2 (Seipin) | Lipid droplet and membrane trafficking protein | Governs caveolin-1 trafficking via sphingolipid-glycerolipid balance |
| CAV1 | Caveolar structural protein | Trafficking influenced by seipin and sphingolipid balance |
| SF1 (NR5A1) | Nuclear receptor and transcription factor | Characterized as a sphingolipid-binding protein |
| SPTLC1 | Serine palmitoyltransferase subunit | Core sphingolipid biosynthesis enzyme in the context of sphingolipid binding |
| SPTLC2 | Serine palmitoyltransferase subunit | Core sphingolipid biosynthesis enzyme in the context of sphingolipid binding |
| CERS1-CERS6 | Ceramide synthases | Generate sphingolipid species that can be bound by proteins |
| SMPD1 | Acid sphingomyelinase | Produces ceramide from sphingomyelin, affecting ligand availability |
| ASAH1 | Acid ceramidase | Regulates sphingosine and ceramide levels |
| SGMS1 | Sphingomyelin synthase | Controls sphingomyelin and ceramide balance |
| UGCG | Glucosylceramide synthase | Produces glycosphingolipids relevant to binding proteins |
| GPCRs (family) | Membrane receptors | Contain a sphingolipid-binding motif |
| Proinsulin processing machinery | Hormone maturation | Affected by sphingolipid subtypes |
| Blood-brain barrier model components | Barrier function | Used to study sphingolipid metabolism in metastasis |
How Is sphingolipid binding Regulated?
Sphingolipid binding is regulated at multiple levels. The availability of sphingolipid ligands depends on biosynthetic and degradative enzymes, as illustrated by SPTLC3 shaping plasma membrane sphingolipid composition. Signaling inputs can also modulate sphingolipid metabolism; the adipokine IL-11/IL-11Ra axis constrains sphingolipid metabolism in beige adipocytes. In addition, the balance between sphingolipids and glycerolipids influences protein trafficking, as shown for seipin and caveolin-1. These layers of regulation mean that sphingolipid-binding events are context-dependent and can be remodeled by metabolic and signaling changes [2,4,6].
sphingolipid binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| RBM10 | Brain metastasis in EGFR-mutant lung adenocarcinoma | Knockout in lung adenocarcinoma cells and blood-brain barrier models |
| SPTLC3 | Hepatic gluconeogenesis and glucose homeostasis | Liver-specific knockout or overexpression in hepatocytes |
| IL11 / IL11RA | Thermogenic capacity of beige adipocytes | Knockout or overexpression in adipocyte models |
| BSCL2 (Seipin) | Caveolin-1 trafficking and lipid balance | Knockout or point-mutation in cultured cells |
| SF1 (NR5A1) | Sphingolipid binding in endocrine regulation | Binding assays and knockout in steroidogenic cells |
Cancer and metastasis
Sphingolipid metabolism and binding are implicated in cancer progression. RBM10 deficiency promotes brain metastasis by modulating sphingolipid metabolism in a blood-brain barrier model of EGFR-mutant lung adenocarcinoma, indicating that sphingolipid-related pathways can influence metastatic dissemination. Because sphingolipid-binding proteins can affect membrane organization and signaling, they represent candidate targets for understanding tumor cell behavior [1,5].
Metabolic and endocrine disorders
Sphingolipid biology is linked to glucose homeostasis and insulin processing. Sphingolipid subtypes differentially control proinsulin processing and systemic glucose homeostasis, connecting specific lipid species to endocrine function. SPTLC3 regulates plasma membrane sphingolipid composition to facilitate hepatic gluconeogenesis, linking sphingolipid composition to liver glucose production. IL-11/IL-11Ra signaling constrains sphingolipid metabolism to limit thermogenic capacity, tying sphingolipid biology to energy expenditure.
Neurodegeneration and membrane trafficking disorders
Sphingolipids are abundant in the nervous system, and proteins that bind or remodel them can influence membrane trafficking. Seipin governs caveolin-1 trafficking through modulating sphingolipid-glycerolipid balance, a process relevant to membrane organization. Although direct links between GO:0046625 and specific neurodegenerative diseases require further study, the broad roles of sphingolipid-binding proteins in membrane biology make this an active area of investigation [1,6].
From sphingolipid binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a candidate protein directly bind sphingolipids? | Recombinant protein with lipid-binding assays and mutant versions [1,8] |
| Is a sphingolipid-binding motif required for receptor function? | Point-mutation of the motif in GPCRs followed by functional assays |
| Does loss of a sphingolipid metabolic gene alter physiology? | CRISPR knockout in cell or animal models [4,5] |
| Does a specific sphingolipid species control hormone processing? | Knockout or lipid supplementation in endocrine cell models |
| Does a trafficking protein require sphingolipid balance? | Knockout or tagged knock-in of seipin and caveolin-1 |
| Does an adipokine constrain thermogenesis via sphingolipids? | Knockout or overexpression of IL-11/IL-11Ra in adipocytes |
How to Study the sphingolipid binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Lipid overlay assay | Binding of protein to immobilized lipids | Screening sphingolipid specificity |
| Liposome binding assay | Interaction with lipid bilayers | Testing membrane-dependent binding |
| Surface plasmon resonance | Binding affinity and kinetics | Quantifying protein-sphingolipid interactions |
| Mass spectrometry lipidomics | Sphingolipid species and abundance | Linking genotype to lipid composition [4,7] |
| CRISPR knockout | Loss-of-function phenotype | Testing causal roles of sphingolipid-related genes [4,5] |
| CRISPR point mutation | Effect of specific residues | Testing binding motifs in receptors |
| Fluorescence imaging | Protein and lipid localization | Studying trafficking and membrane dynamics |
| Transcriptomics / proteomics | Gene and protein expression changes | Identifying pathways affected by sphingolipid perturbations [2,5] |
Lipid-protein binding assays
Direct binding of proteins to sphingolipids can be tested using lipid overlay assays, liposome binding assays and surface plasmon resonance. These methods measure whether a purified or recombinant protein associates with specific sphingolipid species and can be combined with mutagenesis of candidate binding motifs [1,8]. Such assays are foundational for assigning GO:0046625 to a gene product.
Lipidomics and mass spectrometry
Mass spectrometry-based lipidomics quantifies sphingolipid species in cells and tissues, revealing how genetic or pharmacological perturbations change the lipid environment in which binding occurs [4,7]. SPTLC3 studies used lipid analysis to link enzyme activity to plasma membrane composition and gluconeogenesis. Sphingolipid subtype analysis has also been used to connect specific lipids to proinsulin processing.
CRISPR perturbation and functional assays
CRISPR knockout, point mutation and overexpression allow causal testing of sphingolipid-binding proteins and metabolic enzymes. For example, RBM10 deficiency was modeled to study brain metastasis and sphingolipid metabolism, and seipin perturbation was used to study caveolin-1 trafficking. These approaches connect molecular binding events to cellular and organismal phenotypes [5,6].
Imaging and trafficking analysis
Fluorescence imaging of tagged proteins and lipid probes can reveal where sphingolipid binding occurs and how it affects protein localization. Seipin and caveolin-1 trafficking studies illustrate how imaging can link lipid balance to membrane protein dynamics. Such methods complement biochemical binding data by providing spatial and temporal context.
How CRISPR Can Be Used to Study GO:0046625 sphingolipid binding
Knockout
CRISPR knockout is used to remove sphingolipid-binding proteins or sphingolipid metabolic enzymes and observe the consequences for lipid composition, signaling and physiology. For example, knockout approaches have been applied to study SPTLC3 in hepatic gluconeogenesis and RBM10 in brain metastasis. Knockout models help determine whether a candidate gene is required for a sphingolipid-dependent process [4,5].
Point Mutation
Point mutation is used to test specific residues or motifs that mediate sphingolipid binding. Because a sphingolipid-binding motif has been identified in G protein-coupled receptors, mutating key residues can directly test whether lipid binding is required for receptor function. This approach separates binding from other protein activities and provides mechanistic evidence for GO:0046625 annotation.
Knock-in
Knock-in of tags or disease-associated variants allows tracking and functional analysis of sphingolipid-binding proteins in their native context. Tagged knock-in of trafficking proteins such as seipin or caveolin-1 can reveal localization changes linked to sphingolipid balance. Knock-in models are also useful for studying how specific sphingolipid species affect hormone processing.
Overexpression
Overexpression of sphingolipid-binding proteins or metabolic enzymes can amplify lipid-dependent phenotypes and test sufficiency. Overexpression of IL-11/IL-11Ra components has been used to study constraints on thermogenic capacity in adipocytes. Overexpression combined with lipidomics can reveal how increased protein levels alter sphingolipid composition and downstream signaling [2,4].
How EDITGENE Supports sphingolipid binding Research
Researchers studying sphingolipid binding-related genes often need to determine whether a candidate gene is causally involved in lipid recognition, metabolism or disease. EDITGENE provides CRISPR-based cell models and screening services that enable functional testing of sphingolipid-binding proteins and the enzymes that generate their lipid ligands.
Contact EDITGENE today to design your custom CRISPR model for sphingolipid binding research.
Frequently Asked Questions About sphingolipid binding
What is GO:0046625 sphingolipid binding?
GO:0046625 is a Gene Ontology molecular function defined as binding to a sphingolipid, a class of lipids containing sphingosine or a closely related sphingoid base.
What genes are involved in sphingolipid binding?
Genes and proteins linked to sphingolipid binding or its metabolic context include SPTLC3, IL11, IL11RA, RBM10, BSCL2 (Seipin), CAV1, SF1 (NR5A1) and various sphingolipid biosynthetic enzymes [2,3,4,5,6].
Why is sphingolipid binding important?
It underlies membrane organization, signal transduction and lipid metabolism, and its disruption is linked to cancer, metabolic disease and altered glucose homeostasis [1,4,5,7].
How do researchers study sphingolipid binding?
Common methods include lipid overlay assays, liposome binding assays, surface plasmon resonance, lipidomics, imaging and CRISPR-based perturbation [1,4,6,8].
Is there a known sphingolipid-binding motif?
Yes, a sphingolipid-binding motif has been identified in G protein-coupled receptors, showing that lipid recognition can be encoded by short sequence elements.
What diseases are associated with sphingolipid binding?
Sphingolipid-related biology has been linked to brain metastasis in EGFR-mutant lung adenocarcinoma, hepatic gluconeogenesis, proinsulin processing and thermogenic capacity [2,4,5,7].
Can CRISPR be used to study sphingolipid binding?
Yes, CRISPR knockout, point mutation, knock-in and overexpression models allow causal testing of sphingolipid-binding proteins and metabolic enzymes [4,5,6,8].
What is the role of SPTLC3 in sphingolipid biology?
SPTLC3 regulates plasma membrane sphingolipid composition to facilitate hepatic gluconeogenesis.
How does seipin relate to sphingolipid binding?
Seipin governs caveolin-1 trafficking through modulating sphingolipid-glycerolipid balance.
What model systems are used for sphingolipid binding research?
Models include cultured cells, adipocytes, hepatocytes, blood-brain barrier models and CRISPR-engineered cell lines [2,4,5,6].
Conclusion
GO:0046625 (sphingolipid binding) defines a molecular function that connects lipid chemistry to protein behavior and cellular physiology. Sphingolipid-binding proteins are structurally diverse and participate in membrane organization, signaling, trafficking and metabolism, with documented roles in cancer, glucose homeostasis and thermogenesis [1,2,4,5,6,7,8]. Continued research using binding assays, lipidomics and CRISPR-based models will clarify how sphingolipid recognition is encoded and how it can be targeted in disease.
References
- 1. Snook CF et al.. 2006. Sphingolipid-binding proteins.. Biochim Biophys Acta 1761(8):927-46 PMID: 16901751
- 2. Liu J et al.. 2026. Adipokine IL-11/IL-11Ra constrains sphingolipid metabolism to limit the thermogenic capacity of beige adipocytes.. Cell Metab 38(8):1618-1632.e4 PMID: 42140185
- 3. Urs AN et al.. 2007. Steroidogenic factor-1 is a sphingolipid binding protein.. Mol Cell Endocrinol 265-266:174-8 PMID: 17196738
- 4. Montefusco D et al.. 2024. SPTLC3 regulates plasma membrane sphingolipid composition to facilitate hepatic gluconeogenesis.. Cell Rep 43(12):115054 PMID: 39661520
- 5. Xu G et al.. 2025. RBM10 deficiency promotes brain metastasis by modulating sphingolipid metabolism in a BBB model of EGFR mutant lung adenocarcinoma.. J Exp Clin Cancer Res 44(1):95 PMID: 40069781
- 6. Carpentier M et al.. 2025. Seipin Governs caveolin-1 trafficking through modulating sphingolipid-glycerolipid balance.. Cell Rep 44(10):116320 PMID: 40986424
- 7. Griess K et al.. 2023. Sphingolipid subtypes differentially control proinsulin processing and systemic glucose homeostasis.. Nat Cell Biol 25(1):20-29 PMID: 36543979
- 8. Shrivastava S et al.. 2018. Identification of Sphingolipid-binding Motif in G Protein-coupled Receptors.. Adv Exp Med Biol 1112:141-149 PMID: 30637695
